Dr. Valencia Humphrey, DRPH, MSC, BCPA

Empowering Patients Elevating Health

“At the heart of effective healthcare is science, evidence-based practice, and a commitment to interprofessional collaboration between healthcare professionals and public health practitioners.” — Dr. Humphrey, Founder & Board Certified Patient Advocate

Consulting

At Insightful Doc Consulting, the patient voice is not an afterthought — it is the foundation of everything we do.

We provide expert consulting to pharmaceutical and biotech organizations developing therapies and research programs that serve real patients. Our work spans patient survey design and refinement, clinical trial diversity strategy, health communication, and patient-centered program evaluation — all informed by the lived reality of the patients at the center of these efforts.

In every engagement, our commitment is the same: evidence-based, equity-centered, and patient-first.

Our facilitation process involves the utilization of implementation science frameworks that enhance our ability to plan for optimal organizational reach, effectiveness, adoption, implementation, and maintenance. These frameworks support a robust strategy for evaluation of intervention effectiveness to ensure the enhancement of organizational and patient outcomes.

General engagements begin at a rate of $150-$350 per hour. We also offer a project-based fee and monthly retainer options for ongoing advisory. We understand that every organization and project is unique. Therefore, our services and pricing structure are tailored to meet your specific needs timelines, and scope of the engagement.

Contact us today to schedule a complimentary scope for fit discovery call.

General Consulting

Quality Control/Assurance strategy

Quality systems

Gap assessments

General advisory


Patient-Centric Strategy

Patient engagement design, PRO development, advocacy integration


Patient input for regulatory submissions

Patient-reported outcome design

FDA/PFDD guidance compliance

Board-certified advocate perspective

Regulatory Submissions

IND/NDA/BLA support with integrated patient perspective


Patient experience data sections

Benefit-risk narrative development

Advisory committee preparation

Post-market patient safety strategy